SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
Detailed information on the immune response after second vaccination of cirrhotic patients and liver transplant (LT) recipients against SARS-CoV-2 is largely missing. We aimed at comparing the vaccine-induced humoral and T-cell responses of these vulnerable patient groups.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Darius F. Ruether, Golda M. Schaub, Paul M. Duengelhoef, Friedrich Haag, Thomas T. Brehm, Anahita Fathi, Malte Wehmeyer, Jacqueline Jahnke-Triankowski, Leonie Mayer, Armin Hoffmann, Lutz Fischer, Marylyn M. Addo, Marc L ütgehetmann, Ansgar W. Lohse, Juli Source Type: research
More News: Cirrhosis | Gastroenterology | Liver | Liver Transplant | SARS | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines